[Experiments in sensitization to ethyl-3,5,6-tri-O-benzyl-D-glucofuranoside (C. 21 401-BA)].
D000818:Animals; D000937:Antigen-Antibody Reactions; D001593:Benzyl Compounds / Q000009:adverse effects; D004168:Diphtheria Toxoid; D003875:Drug Eruptions / Q000097:blood / Q000209:etiology; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000276:immunology; D005947:Glucose / Q000009:adverse effects*; D006027:Glycosides / Q000009:adverse effects*; D006168:Guinea Pigs; D006386:Hemagglutination Tests; D006801:Humans; D007106:Immune Sera; D010323:Passive Cutaneous Anaphylaxis; D010400:Penicillin G; D012882:Skin Tests; D014373:Tuberculin
D001593:Benzyl Compounds; D004168:Diphtheria Toxoid; D006027:Glycosides; D007106:Immune Sera; D014373:Tuberculin; D005947:Glucose; D010400:Penicillin G
Uber Sensibilisierungsversuche gegenüber Athyl-3,5,6-tri-O-benzyl-D-glukofuranosid (C. 21 401-BA.